百濟神州(06160.HK)擬發行人民幣股份申請獲科創板股票上市委員會審核通過
格隆匯6月28日丨百濟神州(06160.HK)公吿,內容關於(其中包括)本公司建議根據一般授權發行人民幣股份及於科創板上市。科創板股票上市委員會於2021年6月28日召開會議審議並通過本公司上市申請,該結果已於2021年6月28日在上海證券交易所科創板股票發行上市審核網站(http://kcb.sse.com.cn)公佈。
建議根據一般授權發行人民幣股份及於科創板上市的完成須(其中包括)受限於市場狀況及取得其他適用的監管批准,包括中國證券監督管理委員會同意註冊。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.